EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,564,361 | +1.9% | 352,907 | 0.0% | 0.06% | +40.9% |
| Q3 2022 | $3,497,000 | +1.2% | 352,907 | 0.0% | 0.04% | +18.9% |
| Q2 2022 | $3,455,000 | -2.2% | 352,907 | -2.7% | 0.04% | +37.0% |
| Q1 2022 | $3,532,000 | +82.2% | 362,618 | +81.3% | 0.03% | +68.8% |
| Q4 2021 | $1,938,000 | +0.2% | 199,998 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $1,934,000 | -0.7% | 199,998 | 0.0% | 0.02% | +14.3% |
| Q2 2021 | $1,948,000 | – | 199,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |